MediFind
Condition

Metastatic Pleural Tumor

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Nonsquamous Non-small Cell Lung Cancer
  • Journal: Thoracic cancer
  • Treatment Used: Bevacizumab plus Chemotherapy
  • Number of Patients: 20
  • Published —
In this study, researchers evaluated the safety and effectiveness of using bevacizumab plus chemotherapy for the treatment of nonsquamous non-small cell lung cancer patients with malignant pleural effusion that cannot otherwise be controlled.
Latest Advance
Study
  • Condition: Malignant Pleural Effusions
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Various
  • Number of Patients: 5507
  • Published —
In this study, researchers sought to determine the best treatment for malignant pleural effusions in patients with cancer.
Latest Advance
Study
  • Condition: Epithelioid Mesothelioma with High Clonal PD-L1 Expression and EML4-ALK Rearrangement
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Anti-PD-1 Therapy
  • Number of Patients: 1
  • Published —
This case report discusses a 45-year-old woman diagnosed with malignant epithelioid pleural mesothelioma with brain metastasis and peritoneal carcinosis, refractory to initial standard chemotherapy treatment treated with the anti-PD1 agent, pembrolizumab.
Latest Advance
Study
  • Condition: Malignant Pleural Effusion
  • Journal: Respiration; international review of thoracic diseases
  • Treatment Used: pleurodesis
  • Number of Patients: 183
  • Published —
The purpose of the study was to describe quality of life status before and after pleurodesis in patients with malignant pleural effusion.
Latest Advance
Study
  • Condition: Unresectable Malignant Pleural Mesothelioma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Cediranib
  • Number of Patients: 92
  • Published —
This trial evaluated the effectiveness of Cediranib in patients with unresectable malignant pleural mesothelioma.
Latest Advance
Study
  • Condition: Thoracic Surgery for Carcinomas
  • Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • Treatment Used: Hyperthermic Intrathoracic Chemotherapy (HITOC)
  • Number of Patients: 0
  • Published —
This study discusses hyperthermic intrathoracic chemotherapy (HITOC) as an additive procedure after surgical cytoreduction of the pleural tumor manifestation.
Latest Advance
Study
  • Condition: Mesothelioma
  • Journal: La Radiologia medica
  • Treatment Used: Extra-Pleural Pneumonectomy (EPP) and Adjuvant Radiotherapy (RT) Using Image-Guided Intensity-Modulated Radiotherapy (IG-IMRT)
  • Number of Patients: 54
  • Published —
This study assessed the outcome of malignant pleural mesothelioma patients treated with extra-pleural pneumonectomy (EPP) and adjuvant radiotherapy (RT), using the most advanced radiotherapeutic techniques, namely image-guided intensity-modulated RT (IG-IMRT).
Latest Advance
Study
  • Condition: EGFR Mutation-Positive Non-Small-Cell Lung Cancer
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Gefitinib
  • Number of Patients: 50
  • Published —
This study evaluated the effectiveness of continuation of gefitinib (chemotherapy) in patients with non-small-cell lung cancer (NSCLC; any type of epithelial lung cancer other than small cell lung carcinoma) beyond progression.
Latest Advance
Study
  • Condition: Malignant Pleural Effusion
  • Journal: The Lancet. Respiratory medicine
  • Treatment Used: Aggressive vs. Symptom-Guided Drainage
  • Number of Patients: 87
  • Published —
This study compared aggressive versus symptom-guided drainage via indwelling pleural catheters in the treatment of malignant pleural effusion (fluid in the lungs).
Latest Advance
Study
  • Condition: Lung adenocarcinoma-induced malignant pleural effusion
  • Journal: Thoracic cancer
  • Treatment Used: Bevacizumab combined with chemotherapy
  • Number of Patients: 21
  • Published —
The study researched the effects of Bevacizumab combined with chemotherapy for patients with lung adenocarcinoma-induced malignant pleural effusion.